Track topics on Twitter Track topics that are important to you
BiomX has acquired RondinX, expanding its bacterial target discovery platform and adding new microbiome targets for chronic liver disease. BiomX is a company based in Ness Ziona, Israel, developing customized phage therapy to selectively destroy the bacteria that cause diseases ...
This awesome article Israeli Biotech Acquires Microbiome Company to Fight Chronic Liver Disease appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)NEXT ARTICLE
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...